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ABSTRACT 
 
Ram Vanam M.S., Indiana University, December 2004. Electrostatic modeling of protein 
aggregation. Research Advisor: Paul L. Dubin 
 
  Electrostatic modeling was done with Delphi of insight II to explain and predict 
protein aggregation, measured here for β-lactoglobulin and insulin using turbidimetry and 
stopped flow spectrophotometry. The initial rate of aggregation of β-Lactoglobulin was 
studied between pH 3.8 and 5.2 in 4.5mM NaCl; and for ionic strengths from 4.5 to 
500mM NaCl at pH 5.0. The initial slope of the turbidity vs. time curve was used to 
define the initial rate of aggregation. The highest initial rate was observed near pH < pI 
i.e., 4.6 (< 5.2). The decrease in aggregation rate when the pH was increased from 4.8 to 
5.0 was large compared to its decrease when the pH was reduced from 4.4 to 4.2; i.e., the 
dependence of initial rate on pH was highly asymmetric. The initial rate of aggregation at 
pH 5.0 increased linearly with the reciprocal of ionic strength in the range I = 0.5 to 
0.0045M. Protein electrostatic potential distributions are used to understand the pH and 
ionic strength dependence of the initial rate of aggregation. Similar studies were done 
with insulin. In contrast to BLG, the highest initial aggregation rate for insulin was 
observed at pH = pI. Electrostatic computer modeling shows that these differences arise 
from the distinctly different surface charge distributions of insulin and BLG.  
 
 
 
I. INTRODUCTION 
 
Increased of biomolecular structures coupled with rapid developments in 
computational speed and visualization tools has made it possible to model and visualize 
complex electrostatic features of proteins. The resulting study of electrostatic protein 
surfaces yields insight into protein interactions. The most important aspect of protein 
surface potentials is in the identification and prediction of binding sites for ligands of 
varying size and complexity. The behavior of some less studied proteins can be inferred, 
which could facilitate the development of new therapeutic drugs and enhance our 
understanding of complex molecular pathways. 
 
I.A.  Structural Bioinformatics 
 
Bioinformatics has been referred to as an interdisciplinary science that involves 
both conceptual and practical tools for the understanding, generation, processing and 
propagation of biological information1. The rapid increase in the number of 3D 
macromolecular structures available in databases such as the Protein Data Bank (PDB) 
has lead to the emergence of a sub discipline of bioinformatics: structural bioinformatics. 
Structural bioinformatics is a novel branch of biology which uses computational methods 
of analysis with the aim of modeling the 3D structures of proteins and macromolecular 
complexes 2.  
 
 
 I.B. Protein Structure and Function 
 
 In order to function, proteins must fold into their native, three-dimensional 
conformations. This folding is a consequence of the arrangement of linear chains of 
amino acids that differ due to the chemical properties of their R-groups (side chains). 
Interactions between contiguous amino acids leads to local folding of the amino acids 
chain (secondary structure) and then subsequent folding to give the overall shape of the 
protein (tertiary structure). The function of any specific protein is inseparable from its 
three-dimensional structure. 
 Proteins interact with other molecules – small molecules, other proteins, nucleic 
acids, and so forth – and these interactions are the basis of biological function. Proteins 
play a key role in cell division, cellular communication, metabolism, thus enforcing the 
activities encoded by genes. Protein interactions are central to the understanding of any 
cellular processes, and the corresponding studies flood the literature. Forces governing 
protein interactions include hydrogen bonding, hydrophobic forces, van der Waals forces, 
and electrostatic forces. Electrostatic interactions play a key role in governing the role of 
structure many important macromolecular processes such as molecular recognition, 
enzyme catalysis and the folding of nucleoprotein complex. 
 
 
 
 
II. BACKGROUND 
 
II.A.  Protein Electrostatics 
 
 Proteins contain charged and polar groups, and electrostatic interactions control 
important aspects of their structure and function. These are long range, directionless 
(scalar), non-specific coulombic interactions that are important in understanding protein 
folding, stability, and function.  These forces exert their influence over several 
nanometers in contrast to other short range electrostatic forces like salt bridges 
(interaction between two charged residues at very low dielectric constants) which are 
well oriented and short range. It is now quite clear that electrostatic effects play a major 
role in enzyme catalysis, electron transfer, proton transport, ion channels, ligand binding, 
macromolecular assembly, and signal transduction. They contribute to Protein – DNA 
interactions which are essential to genetic regulation of transcription, replication, 
translation and recombination. Complementarity was recognized by Nakamura and 
Wada, 19853 who  illustrated its role in between ligand–protein and protein-protein 
surface interactions.  
Electrostatics play an important role in catalytic reactions of proteins. Efficient 
enzyme catalysis is based on the decrease in the free energy of the transition state, and is 
mediated by a well-designed active site structure and electrostatic field4-5. For example, 
Asp 32 in subtilisin is believed to stabilize the protonated form of His64 in the transition 
state complex and to accelerate the catalytic reaction6. Similarly, unusual pKa values of 
ionizable residues have often been found at the active sites of enzymes. In hen egg-white 
lysozyme, an unusual ionization behavior has been observed for the catalytic 
carboxylates of Glu35 and Asp527.  
 Many models have been used to study protein electrostatics. These range from 
complex microscopic models which include atomistic details in the calculation of 
electrostatic energies (e.g., density function calculations, hybrid quantum mechanics-
molecular mechanics, molecular dynamics or Monte Carlo simulations), to comparatively 
simple and reliable macroscopic models with no atomistic details (e.g., Poisson-
Boltzmann, modified Tanford-Kirkwood model, generalized Born model)8-19 and, 
bridging the gap between two, semi-macroscopic models (e.g., dipolar models). The 
Poisson–Boltzmann treatment constitutes one of the most fundamental approaches to 
treat electrostatic effects in solution. Simple electrostatic models for globular proteins 
based on the Poisson-Boltzmann equation or its linear approximation were put forward 
quite early19-22. In subsequent years, enhancements of the nonlinear Poisson-Boltzmann 
equation with multiple dielectric constants, and new methods to decompose the energy 
terms to remove the dependency on the lattice grid (into which the proteins are mapped), 
have been reported23. These models, involving the Poisson-Boltzmann equation 
(linearized or not) have led to quite accurate computation of electrostatic potential at the 
solvent-accessible molecular surface, to computation of reaction rates between molecules 
in the solution, and to computation of the free energy of association of macromolecules 
and its salt dependence. 
Electrostatic potential visualization helps in the identification of functional sites at 
the surface of a protein24. Electrostatic potentials can be visualized either by displaying 
isopotential surfaces or by color coding the molecular surface according to potential 
values. Structural alignments based upon electrostatic potentials can provide important 
information about protein functions25. They may also identify residues that are 
functionally important26.  
 
II.B.     Protein Aggregation and Electrostatics 
 
II.B.1 Definition and Importance 
 
Aggregates are operationally defined by three characteristics. First, they exhibit  
 
Word Phenomenon Degree of 
polymerization 
Induction Cause 
Association Multimer formation Unique Natural Electrostatic 
Short range 
Association/ 
Aggregation 
with out loss of native 
state or solubility but 
no precise organization 
finite Concentrati
on, Non-
physiologic
al 
conditions 
Hydrophobic 
Electrostatic 
Partial 
desolvation 
Association/ 
Aggregation 
loss of solubility; 
reversible  
native state retained 
salting out isoelectric 
precipitation 
Infinite Salt 
Co-solvents 
Desolvation 
Aggregation loss of solubility and 
native state due to 
denaturing conditions 
(often irreversible) 
Infinite Denaturing  
conditions 
Exposure of 
internal 
groups 
 
Table 1. Terminology of association/aggregation used in literature and forces involved. 
 
poor solubility in aqueous or detergent solvents. Second, they appear in aberrant 
subcellular or extracellular locations. Lastly, they exhibit secondary or tertiary structure 
that are not found in the normal native state. The terms “association” and “aggregation” 
are used interchangeably based on the types of protein assembly. “Association”, but not 
“aggregation”, may be used to describe multimerization wherein a protein stays soluble 
in the solution and is biologically functional. “Association” or “aggregation” may both be 
used when the protein assembly involves no precise organization but there is no loss of 
native state or solubility. “Aggregation”, but not “association”, is employed when there is 
a loss of both solubility and native state due to at least partial unfolding. The process of 
association/aggregation can be reversible or irreversible. Reversible aggregation occurs 
for example when the protein in its native state is subject to salting out or isoelectric 
precipitation. Irreversible aggregation, on the other hand, involves formation of 
misfolded and unassembled proteins typically due to exposure to extremes of pH, 
temperature etc. 
In vitro manifestations of aggregation of native folded proteins are salting out 
(insolubility due to excess protein concentrations) and isoelectric precipitation (when a 
protein has zero net charge at its pI). Examples of in vivo manifestations of protein 
aggregation are inclusion bodies27 (structures that contain extremely high concentrations 
of aggregated protein, formed in cells either to express heterologus/mutant proteins or 
upon over-expression of some endogenous protein), and Amyloids28 (deposits of protein 
in the form of fibrils). 
  
 Protein aggregation is a major problem in disease states, technological processes, 
and research. Disease states included type II diabetes29, Parkinson’s disease30, and 
Alzheimer’s diseases30 resulting from aberrant folding or processing events. However, 
protein aggregation need not be pathogenic. For example, in yeast, cytoplasmic 
inheritance of aggregated prion proteins underlies the propagation of stable epigenetic 
traits that are not associated with any known pathology31. Other consequences of protein 
aggregation arise in the biotechnological development of drugs32, the production of 
recombinant proteins33, and in studies of protein folding and stability. The enormous 
impact of disease states and the growing number of protein drugs have given rise to 
intense research of both equilibrium and dynamic aspects of protein aggregation, with the 
ultimate objective of learning to manipulate the protein chemistry and system conditions 
in ways that will preclude or slow down disease process. 
 
II.B.2  Protein aggregation and electrostatics 
 
  Electrostatics is one of a number of factors effecting aggregation. In particular, it 
is believed that screening of electrostatic repulsions is a prerequisite for aggregation 
because it was assumed that electrostatic interactions oppose protein-protein association 
processes. However, growing evidence suggests that charged groups can contribute 
favorably to the stabilization of protein complexes32. The rate of association is governed 
by diffusion and can be increased by favorable coulombic electrostatic forces34-35. 
Conversely, the rate of dissociation is dictated by the strength of short range interactions 
between the proteins (van der waals interactions, hydrogen bonds, hydrophobic 
interactions and salt bridges)36. 
It is still not clear to what extent electrostatic interactions can contribute to the 
stabilization of protein-protein complexes. However, it is known that electrostatic fields 
around proteins can increase the rates of protein-protein association37-39 and that 
electrostatic interactions have an effect on the specificity of protein-protein association. 
The role of electrostatics in protein-protein association can be manifested in binding 
strengths, specificity, or rates of association. For they account for an increase in the rates 
of protein association between TEM1 beta-lactamase and its protein inhibitor BLIP by 
250-fold36. Upon incorporating charged residues in the vicinity of the BLIP binding 
surface. Electrostatics has been implicated in multimerization of human arylsulfatase A 
(ASA, EC 3.1.6.8) an enzyme that occurs in the lysosome of the human cell, where acidic 
pH values prevail40. ASA forms octamers in an acidic environment (pH ≤ 6) and 
dissociates to dimers at higher pH values, and the pH-regulated association between 
dimers of ASA has been explained on the basis of electrostatic interactions. Encounter 
complex formation between barnase and barstar is increased by an interactive long range 
force strong enough to influence the translational and rotational Brownian motion of the 
proteins before the complex is formed41. It has been shown by Ferhst and co-workers42 
that barstar looses its stability to rapidly associate with barnase in forming a cluster of 
negatively charged residues facing barnase. It was proposed that long-range electrostatic 
force could promote the formation of encounter complexes, which accelerate the rate of 
complex formation and lifetime of complexes40,43.  
 
II.B.3. Aggregation behavior of proteins under study 
 
II.B.3.1.Beta Lactoglobulin 
 
The structure of Bovine β-lactoglobulin (BLG), the most abundant protein in 
cow’s milk whey, is well understood. Its physiological function is still a mystery44, but it 
seems to be involved in transport of small, sparingly soluble molecules such as retinol or 
fatty acids, although species distribution and variation in binding profile do not all fit 
such a role45. The native state is a dimer of identical units, each unit containing 162 
amino acid residues (18kD). Each monomer in it contains two disulfide bonds (Cys66-
Cys160 and Cys106-Cys119) and a free thiol (Cys121). It is predominantly a β-sheet 
protein consisting of nine β-strands (A – I) and one major α- helix at the C-terminal. 
Some 10 variants of the BLG have been identified, but by far the most common are the A 
and B forms that differ in only two places: Asp64Gly and Vall118Ala44. 
 
Multimerization of BLG is electrostatic and associates readily at low ionic 
strength at pH close to its pI46. At room temperature, BLG exists as a monomer, dimer or 
can self-associate to an octamer47-49. The monomeric form predominates below pH 349-51 
and above pH 953, but coexists in equilibrium with dimers in the pH ranges 2.0-3.7 and 
5.2-9.0, whereas dimers and higher order aggregates were reported between pH 3.7 and 
5.254-56. These higher-order aggregates at pH 4.7 were reported to be octamers50,54,57. 
Ionic strength seems to have some influence on the aggregation of BLG, aggregation 
decreasing with increase in ionic strength53, 58-59. The pH and ionic strength regulation of 
BLG association/dissociation suggests that it may be governed by electrostatic forces. 
Electrostatics interactions play a significant role in BLG aggregation. In BLG as 
for other proteins, it is important to understand the forces that drive association and 
consequently to be able to regulate these forces by external parameters. A number of 
forces have been proposed to significantly influence the strength, specificity, and rate of 
association. Piazza and Lacopini60 showed that a possible result of attractive interactions 
in BLG A solutions is the spontaneous formation of transient clusters but did not specify 
the nature of the interactions. Recent investigations showed that salt bridges stabilize the 
BLG dimer by decreasing the electrostatic repulsion between protomers at pH 3.049. 
However, theoretical investigations showed that electrostatic interactions can have a 
stabilizing effect on protein protein binding61. 
  
II.B.3.2. Insulin 
 
Insulin is one of the most intensely studied biomolecules in biochemistry. Its 
chemical sequence determined in 1955 was the first established for any protein62-63 and 
its three dimensional structure of the molecule was determined by X-ray 
crystallography64 in 1969. Insulin performs the role of increasing the uptake of glucose in 
the body cells upon detection of elevated sugar in the blood stream by pancreas. An 
inability to produce sufficient levels of insulin can result in diabetes mellitus.  In 1967 it 
was discovered that insulin is synthesized in the B-cells of the Islets of Langerhans, 
where a single chain of preproinsulin is converted to proinsulin, which is subsequently 
converted enzymatically to insulin in the storage vesicle65.  
 Insulin is one of the most frequently studied self associating proteins, exhibiting a 
complex association pattern consisting of monomer, dimer, tetramer, hexamer, and 
higher-order species66-74. The 5800Da monomer consists of an A chain with 21 residues 
(which are denoted by A1-A21), and a B chain, 9 residues longer (B1-B30), held together 
by two inter-chain disulphide bonds (between A7 and B7, as well as A20 and B19), while 
an additional disulphide connects A6 and A11 within the A chain. This “monomer” 
multimerizes readily to form dimers, which are stable in aqueous solution in pH 2 and 8. 
In the presence of zinc and calcium ions, three such dimers assemble to form a hexamer 
of insulin monomers66, which is stable between pH 5 and 8.   This pattern of assembly is 
utilized in the biosynthesis, processing and storage of the hormone. Upon extracellular 
release, the hexamers dissociate into dimers and eventually into monomers which are the 
biologically active species. It has been found that the strongest subunit interactions are 
between dimers, and that if these interactions could be disrupted, then the association to 
hexamers could be stopped. Numerous models have been proposed to explain insulin 
self-association75-76; however, the molecular mechanism of insulin aggregation remains 
substantially unknown. 
 
 
 
 
 
III. PROPOSAL 
 
III.A. Knowledge gap 
 
Protein aggregation is a complex phenomenon that can occur in vitro and in vivo, 
resulting in the loss of the protein’s biological activity. Numerous studies have been 
carried on aggregation of beta lactoglobulin and insulin; but no specific studies focusing 
on the mechanism of aggregation have been proposed. More over a clear understanding 
of the role of electrostatics in the aggregation process is lacking. 
 
 
III.B. Objectives 
 
The objectives of this work were two fold.  
1. The first was to investigate pH and ionic strength dependence of BLG 
aggregation, and to use computer modeling to understand the role of electrostatics 
in protein this aggregation. 
2. The second was to use electrostatic computer modeling for predicting aggregation 
behavior of insulin. 
 
III.C. Intended research project 
1. pH dependence of initial rate of aggregation of BLG studied at a constant ionic 
strength of 4.5mM by colorimetry. 
2. Ionic strength dependence of initial rate of aggregation of BLG studied at pH 5.0 
by colorimetry. 
3. pH dependence of aggregation rate for different genetic variants studied at 
constant ionic strength of 4.5mM by stopped-flow spectrophotometry. 
4. Electrostatic modeling of BLG dimer to explain the pH and ionic strength 
dependence of initial rate of aggregation. 
5. To predict aggregation behavior of insulin using electrostatic modeling. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IV. ORGANIZATION OF THESIS 
 
The current work is a continuation of previous aggregation studies of BLG. An in 
depth understanding of the aggregation mechanism was achieved through experimental 
observations coupled with electrostatic modeling. In this thesis, further research on the 
aggregation of BLG including role of genetic variants was conducted using stopped-flow 
spectrophotometry, rather than conventional colorimetry. With a thorough understanding 
of the aggregation of BLG, the aggregation studies were extended to insulin. Insulin 
aggregation was studied using electrostatic modeling as a predictive base. BLG was 
written as Results followed by Discussion, in order to discuss colorimetry, QELS, 
modeling and theory together. For insulin we focus on difference from BLG which 
appears with simple pH and ionic strength studies from colorimetry.  
 
 
 
 
 
 
 
 
 
 
 
V. METHODS 
 
V.A.  Materials 
 
 Most studies were carried with β-Lactoglobulin A&B (no. L-2506-5G, Lot 
032K7035) from Sigma-Aldrich (St Louis, MO). Lot to lot variability was explored using 
lots 101K7031, 20K7023. To define the role of genetic variants, we used BLG A (no. 
L7880-25MG, Lot 031K7052) and BLG B (no. L8005-25MG, Lot 011K7032). Human 
insulin, LY41001(Lot KG5-WEF-179) was obtained from Eli Lilly and Company. pH 
was adjusted with 0.1N hydrochloric acid and/or 0.1 N sodium hydroxide solutions. All 
solutions were made from Milli-Q water (Millipore, Milliford, MA). 
 
V.B Methods 
 
V.B.1 Sample preparation 
 
1 g/L BLG solutions were prepared in NaCl solution at appropriate ionic strength 
by stirring  for at least 15 min and filtering with 0.22 μm filters (Sartorius AG, Germany) 
prior to use. Solutions were then adjusted to pH 9.0 to ensure formation of stable 
monomer. Two methods were employed to bring this solution to the desired initial pH.  
 
 
 
V.B.2 Mixing technique 
 
BLG at pH 9.0 was rapidly mixed with a predetermined solution of HCl in NaCl 
to bring the pH from 9.0 to the target pH. Similar sample preparation and mixing 
technique were also used in experiments carried out with insulin. The amount of acid 
added was negligible and its effect on ionic strength can be neglected. The target pH was 
attained within about 5 seconds.  
 
V.B.3  Stopped-flow spectrophotometer 
 
The stopped flow experiments were performed at room temperature (23°C) of 
BLG with a Hi-Tech Scientific SF-61SX2 kinetasyst stopped-flow spectrophotometer, 
equipped with a 75 W Xenon lamp. All measurements were made in absorbance mode at 
420nm.  A solution of BLG pH 2 g/L at pH 9.0 was mixed with an equal amount of 
4.5mM NaCl solution containing the calculated amount of acid to bring the pH to a target 
value. The data was converted to 100 - %T before analysis. 
 
V.B.4. Turbidimetric titration 
 
Turbidity measurements of BLG or insulin reported as 100-%T, were performed 
at 420 nm   using a Brinkman PC 800 probe colorimeter equipped with a 1cm path length 
probe, calibrated to 100% transmittance with Milli-Q water. The pH was measured with 
an Orion 811 pH meter equipped with a Beckman refillable combination pH electrode 
and calibrated with pH 7 and pH 4 buffers. % T was monitored with time after the target 
pH was attained using the  sample preparation technique described above.  
 
V.B.5. Dynamic light scattering (DLS) 
 
A DLS system from Brookhaven Instruments(Holtsville, NY) equipped with a BI-
9000AT digital autocorrelator and a 488 nm, 100 mW argon-ion laser was used to 
measure the particle size of BLG at 90° scattering angle for pH values 5.2 and 5.4. 
Measurements at pH 4.0 and 4.2. Measurements every 30sec were carried out with a 
Malvern zetasizer (Malvern Instruments). The mean apparent translational diffusion 
coefficients were obtained by fitting the autocorrelation function using NNLS 
(Brookhaven) or a “       “(Malvern). The hydrodynamic radius (Rh) of the particles was 
determined from Stokes-Einstein equation. 
Rh    = Kb T / 6πηDT                                       (1) 
where Kb is Boltzmann’s constant, T is the temperature , and η is the solvent viscosity.  
 
V.B.6. Initial rate determination 
 
Initial rate of aggregation for BLG or insulin was determined from the initial 
slopes of turbidity vs. time curves. The first ninety seconds data was used for 
determination of rates for both BLG and insulin. The rates were determined using 
Microsoft excel. This is illustrated in figure 2 and described in detail.  
 
V.B.7. Computational methods 
 
  Computer modeling allows visualization of the electrostatic potential around the 
protein as a function of pH and ionic strength. In Delphi V98.0 (Molecular Simulations 
Inc), the electrostatic potential around the protein is calculated by nonlinear solution of 
the Poisson–Boltzmann equation. The protein crystal structures with Protein Data Bank 
identification 1BEB.pdb were taken from RCSB Protein Data Bank 
(http://www.rscb.org). The deposited structure 1BEB.pdb has A variant Val at position 
118, and B variant Gly at 64. This corresponds neither to BLG A (Asp64, Val118) nor to 
BLG B (Gly64, Val118). In order to rectify this incorrect amino acid sequence, the 
charge file used for the electrostatic calculations was modified by replacing the Gly64 
with Asp64 to mimic a BLG A dimer. The BLG B dimer was not considered because the 
association of BLG A dimer appears to dominate aggregation effects. Modeling studies 
for insulin were carried out with dimer (1ZNI.pdb).  The charges of the amino acids in 
the proteins were determined using the spherical-smeared –charged model put forward by 
Tanford77  utilizing the protein titration curve of BLG78 and insulin79. 
 
 
 
 
 
 
 
VI. RESULTS AND DISCUSSION 
 
VI.A. β LACTOGLOBULIN 
 
VI.A.1 RESULTS 
 
VI.A.1.1.Effect of pH 
 
Figure 1 shows the Turbidimetric response of 1g/L BLG in 4.5mM NaCl at 
various initial pH values obtained by colorimetry. The pH drift during the course of the 
experiment was ≤ 0.01 pH units. Time zero corresponds to the time at which the target 
pH was attained; at this point the transmittance was equal to 100 ± 0.2%. In the pH range 
4.3 – 5.0, the abrupt initial increase in turbidity is followed by a stable state, but a 
continual increase was observed for the more extreme pH’s. The initial aggregation rates 
expressed as (dτ/dt)0, were obtained as the initial slopes turbidity vs. time as shown in 
figure 2, an expansion of the data in figure 1. As an example, the line drawn for the pH = 
4.59 data 
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Figure 1. Turbidity vs. time for BLG 1g/L, I = 4.5 mM at pH values shown. Data 
obtained by probe colorimeter. 
 
corresponds to the linear best fit by excel for the time interval of 0 – 90 seconds, 
including the origin, and automatically rejecting obvious outliers. This procedure was 
followed in call cases to get (dτ/dt)0.  Extending the data set to 0 – 120 seconds never 
effected (dτ/dt)0. It should be noted that this protocol differs from the earlier work80. In 
earlier work the first two minutes turbidimetric data has been taken for calculation of 
initial rates manually. The slopes were determined by taking the best linear fit. However, 
the initial outliers were rejected and time zero was not considered in determination of the 
rates. 
 Figure 2.  Expanded scale for figure 1 to show method of obtaining initial slope. 
 
 
The pH dependence of BLG aggregation was also monitored using stopped-flow 
spectrophotometry. The data were recorded as absorbance and converted to 100 - %T. 
Similar to the treatment colorimetric data, the initial slopes of 100-%T vs. time were used 
to determine the pH dependence of initial rate of aggregation. Figure 3 shows the pH 
dependence of the initial aggregation rate obtained by both stopped-flow and colorimetry 
data. In both data sets, the highest rate of aggregation was observed at pH 4.6. In contrast 
to the colorimetry data, aggregation rates were not close to zero at pH’s 5.0 – 5.2. In the 
absence of duplicate runs for any given pH, the precision is unknown; some data suggest 
high precision of ± 0.1, but other data show deviations of ± 1. Between pH 4.1 – 4.45 and 
4.7 – 4.85 agreement is good between the two methods. However data points at pH’s 4.6 
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and 5.0 determined by stopped-flow seem to be outliers. Neglecting these outliers, data 
obtained by both colorimetry and stopped-flow photometry are consistent with a single 
curve of pH dependence of initial rate of aggregation.   
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Figure 3.  Initial Rate vs. pH for 1g/L BLG  at 4.5 mM ionic strength for  data obtained 
from turbidimetry ( ) and stopped-flow photometer(O). 
 
VI.A.1.2.Effect of ionic strength 
 
 
Figure 4 shows the turbidimetric response of 1g/L BLG at pH 5.0 for various 
ionic strengths ranging from 0.0045 to 0.5M. Minor changes in turbidity with time were 
observed at I>0.02M. At I<0.1M a sharp increase in turbidity was observed in the first 
few minutes. Ionic strength dependence of initial rate of aggregation was determined 
from the slopes of initial few minutes data, similar to the pH dependence. 
0 10 20 30 40
0
5
10
15
20
25
10
0 
- %
T
Time, min.
 
Figure 4. Turbidity vs. time for 1g/L BLG, pH 5 at different ionic strengths (top to 
bottom I = 0.0045M, 0.006M, 0.008M, 0.02M, 0.1M, 0.3M, 0.5 M). Data obtained by 
probe colorimeter. 
 
VI.A.1.3.Sample Variability 
 
When the ionic strength dependence of initial rates of aggregation was examined 
using different lots of BLG by colorimetry, the data displayed drastic changes in the 
absolute rates.   To further investigate this lot-to-lot variability, the pH dependence of the 
initial rate at I =4.5mM was obtained. As shown in Figure 5, all three lots showed the 
same asymmetry of the pH effect. However, the pH for maximum aggregation ranged 
from 4.6 to 5.2.   
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Figure 5. Initial rate vs. pH for 4.5mM, 1g/L BLG from different (SIGMA) lots. Lot 
20K7023(A); Lot 032K7035 (B); Lot 101K7031 (C). Data obtained by probe 
colorimeter. 
 
VI.A.1.4.Genetic variance 
 
Figure 6 shows turbidimetric response of BLG variants obtained by stopped-flow 
spectrophotometry. In experiments I and IV 0.5 g/L of BLG A or BLG B solutions at pH 
9.0 were rapidly brought to a target pH of 4.8. The resultant solution at pH 4.8 would 
have dimers of BLG A or BLG B as the initial reactants. Results in figure 6 show rapid 
aggregation for BLG A, (I) and negligible aggregation for BLG B (IV).  In II BLG A and 
B were mixed at pH 9.0 to yield a solution of 1 g/L in total protein concentration and then 
brought rapidly to pH 4.8. The resultant solution would have dimers of AA, BB and AB 
as the initial reactants at pH 4.8. Significant aggregation was noticed in (II), however was 
lower compared to (I).  In III BLG A and B were first dissolved at pH 6.0 to yield a 
solution of 1g/L and then mixed at that pH, and brought to 4.8, resulting in dimers of 
BLG A and B as the initial reactants. Results in figure 6 show negligible aggregation for 
III. 
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Figure 6. 100 - %T vs. Time for BLG genetic variants A, B and AB at I = 4.5  mM.  (I) 
0.5 g/L BLG A at pH  4.8;  (II)1g/L final concentration BLG A+B mixture at pH 4.8 
brought down from an initial of pH 9; (III) 1g/L final concentration BLG A+B mixture 
at pH 4.8 brought down from an initial of pH 6 ;  (IV). 0.5g/L BLG B at pH 4.8.  Data 
obtained by stopped-flow spectrophotometry. 
 
VI.A.1.5.Time dependence of particle size 
 
Figure 7 shows the time dependence of particle size for 1g/L BLG in 4.5mM 
NaCl at pH 4.2, monitored by QELS. QELS results  reveal a distinct 6 nm mode at all 
times, which shows the continuous presence of dimers. Two distinct higher order modes 
of 600 – 700 and 200 – 400 nm were also identified at pH 4.2.   
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Figure 7. Time dependence of QELS for 1 g/L BLG; I = 0.0045M; pH 4.2. Time 
dependence of total count rate (upper); apparent diameters (middle); and absolute 
scattering intensity corresponding to each mode (lower). Symbols in lower curves 
identify fast ( ), slow ( ) and intermediate  ( ) modes,  corresponding to  the  
diameters  6 nm, 200-400 nm, and >600 nm, respectively80. 
 
 
 
 
 
 
 
 
VI.B.1.DISCUSSION 
VI.B.1.1..Effect of pH 
 
 
The observation of maximum initial rate of aggregation at pH 4.6, with extreme 
pH sensitivity between 4.6 and 4.9 can be attributed to asymmetry of charge distribution. 
The asymmetry observed could possibly be due to the large changes in the aggregation 
rate  resulting from smaller changes in the pH. The asymmetry of charge and potential 
distributions lead to attractive forces between positive and negative domains of 
associating proteins. These local distributions are strongly influenced by the charge state 
of particular amino acids. These effects are best visualized by electrostatic computer 
modeling, which has been used to understand similar inter-macromolecular phenomena 
related to protein charge heterogeneity36,82.  
Electrostatic modeling was done was done with BLG structure (1BEB.pdb) in the 
previous studies80 which has incorrect amino acid sequence of A variant Val at position 
118; and B variant Gly at 64 which corresponds to neither BLG A (Asp64, Val118) nor 
BLG B (Gly64, Ala118). In order to rectify the incorrect amino acid sequence, the 
charges on the structure were modified by replacing the charge of Gly 64 with that of Asp 
64, to mimic a BLG A dimer. Modeling the deposited structure would give the 
electrostatic models for BLG B dimer because it has the amino acid residues with charges 
corresponding to the BLG B dimer.  
Figure 8 shows potential distributions for the AA dimer to understand the pH 
dependence of initial rate of aggregation observed in figure 3. The negligibly small initial 
rates below pH 4.0 and above pH 5.0, as seen in Figure 3, are due to the net positive and 
negative protein charge respectively, preventing association. At pH 5.0, close to pI, BLG 
shows approximately equal positive and negative lobes, as seen in Figure 8 D. Many 
proteins exhibit diminished solubility near the isoelectric point; this phenomenon, often 
referred to as “isoelectric precipitation”82, is frequently accounted for in terms of minimal 
protein net charge corresponding to minimization of aggregation-inhibiting repulsion. 
However, it is evident here from modeling that (a) aggregation is promoted by 
electrostatic attractive forces, and (b) the net protein charge is not highly relevant to these 
forces. A net protein charge of zero at pH 5.2 and positive and negative lobes of similar 
magnitude do not constitute the condition of maximum aggregation, but instead occurs at 
pH 4.6 where electrostatic potential contours are highly asymmetric. 
While we can visualize how positive and negative domains of similar size could 
support one-dimensional association, the ability of the large positive lobe in Figure 8 B to 
accommodate the small negative domains of several other proteins suggests the 
multidimensional propagation that is required to account for large aggregates. The former 
leads to linear chains of finite length, and the latter to branching to infinite molecular 
weight. This description is analogous to the difference between condensation 
polymerization of A-B type vs. A-(B) 2 monomers83. 
 The possibility of ion-binding, particularly as the binding of chloride ion would 
be expected to contribute to asymmetric potential contours. In order to establish whether 
our neglect of chloride ion binding could introduce a significant error in our modeling we 
repeated calculation after removing two positive charges, corresponding to the maximum 
number of chloride ions bound to BLG. No significant effect on the computed positive 
domain was observed. This enhances our confidence that the large positive domain at the 
pH of maximum aggregation is not susceptible to diminution by ion binding. 
 
 
          (A) 
    
                                                  (B) 
                           (C)         (D) 
 
Figure 8. 0.5(blue) and -0.5(red) kT/e electrostatic potential contours around BLG AA 
dimer at ionic strength 0.0045M at pH (A) 4.03, (B) 4.59, (C) 4.98, (D) 5.22 
 
VI.B.1.2.Effect of ionic strength 
 
 
Figure 9 shows the ionic strength dependence of initial aggregation rate for 1g/L 
BLG at pH 5.0, obtained by colorimetry. A significant increase in initial aggregation rate 
was observed with decrease in I from 0.1 to 0.0045M. As shown in the insert of Figure 5, 
the data are fit well by (dτ/dt)0 = 0.017 I-1 .The significance of this result will be 
discussed later. 
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Figure 9. Initial rate vs. I for 1g/L BLG at pH 5.0.  Insert: Initial rate vs. I -1   
 
Figure 10 addresses the ionic strength dependence of aggregation by electrostatic 
modeling for BLG A dimer. The small variation in the electrostatic domains for ionic 
strengths 0.5 and 0.1 M as seen in Figure 10 account for the negligible differences in the 
initial rates at these ionic strengths. As I decreases below 0.1M, the most dramatic effect 
is the expansion of the positive domain, and the appearance of strong asymmetry between 
positive and negative regions with regard to both shape and magnitude. Figure 10D 
strengthens the hypothesis that BLG aggregates most when it has a distinct negative 
domain and a dominant positive domain. 
               
                        (B) 0.1 M                  (A) 0.5 M 
 
                  (C) 0.02 M        
                            (D) 0.0045 M 
Figure 10. 0.5(blue) and -0.5(red) kT/e electrostatic potential contours around BLG AA 
dimer at pH 5 at ionic strengths (A) 0.5 M, (B) 0.1M, (C) 0.02 M, (D)0.0045M  
 
VI.B.1.3..Kinetic Analysis 
 
The strong increase in the intial rate with decrease in ionic strength, and the linear 
dependence of intial rate on 1/I as seen in figure 9 can be explained by considering 
protein aggregation as a diffusion controlled process. If protein A is diffusing towards 
any other protein, protein B as depicted in Figure 11, the diffusion trajectory of A is 
given as: 
A = ν0 . t          (2) 
where ν0 is the velocity and t is time.  The probability that the diffusion trajectory of A 
  
Figure 11. A simplified picture of protein A diffusing towards protein B. 
 
intersects a cross-sectional area of B should be given by A times the cross sectional area 
density of any other protein. The cross-sectional area density is obtained by multiplying 
the number density of the proteins n/V in cm-3 (where n is the number of proteins and V is 
the total volume of the system) by AB (in cm2). This probability is therefore given by:  
V
AnAP B.=      (3) 
The total probability will be a dimensionless quantity equal to 1, since the probability of 
effective collisions should be equal to unity.  
V
Antv
V
AnAP BB .1. 0 ⋅⋅===   (4) 
The rate of the process is proportional to 1/t, and solving this equality to get the 
expression for the rate  given by 1/t reveals that the rate is directly proportional to the 
cross sectional area AB assuming υB 0 and volume V are constant.  
21 RA
t
rate B ∝∝∝    (5) 
At low ionic strengths, where the Debye length (K-1) is large compared to the protein 
radius, the cross sectional area is therefore proportional to K-1, which is directly 
proportional to 1/I  giving a linear relationship between the initial rate of aggregation and 
1/I.  The uncertain geometry of the positive domain in Figure 10D just gives a 
dependence of (κ-1)a; in the case of a simple sphere a=2. At high ionic strengths, where, 
charges are correctly screened and the collisions in the correct orientation is necessary, 
and a more detailed treatment would be required. 
VI.B.1.4.Sample Variability 
 
 
The marked differences in the aggregation rates of the different lots seen in figure 
5 could not be ascribed to any of the known characteristics of the proteins. It did not 
correlate with sample age (ranging from a few months to more than a year), nor with the 
reported purity of the samples (97% or higher for all lots).  We considered the influence 
of the genetic variants A and B, but the A:B ratio for all lots was close to 1:1. 
Nevertheless, the resultant observations on the aggregation of the genetic variants, 
discussed below, provide some insight into the aggregation seen for Sigma “AB” BLG 
shown in the preceding figure 6.  
 
VI.B.1.5.Genetic Variance 
 
Figure 6 shows turbidimetric response of BLG variants obtained by stopped-flow 
spectrophotometry. In experiments I and IV 0.5 g/L of BLG A or BLG B solutions 
respectively, at pH 9.0 were rapidly brought to a target pH of 4.8. The resultant solution 
at pH 4.8 would have dimers of BLG A or BLG B respectively, as the initial reactants. 
Results in figure 6 show rapid aggregation for BLG A,(I) and negligible aggregation for 
BLG B (IV). In II BLG A and B were mixed at pH 9.0 to yield a solution of 1 g/L in 
total protein concentration and then brought rapidly to pH 4.8. The resultant solution 
would be expected to have some mixture of  dimers of AA, BB and AB as the initial 
reactants . Significant aggregation was noticed in (II), which was however lower than for 
(I).  In III, BLG A and B were first dissolved separately at pH 6.0 to yield a solution of 
1g/L and then mixed at that pH, and then brought to 4.8, resulting in dimers of BLG A 
and dimers of B only as the initial reactants. Results in figure 6 show negligible 
aggregation for III. 
The observations from figure 6 provide some insight into the aggregation seen for 
sigma"AB" BLG shown in figure 3 and 9. In (I) of figure 6, the strong aggregation of the 
AA dimer is consistent with the results of Townsend and Timasheff84 who reported the 
presence of AA oligomers substantially higher than dimers. On the other hand, no 
aggregation is noticed with the BB dimers presumably formed in (IV). The two units of 
the BB dimer both lack the Asp at position 64, present in BLG A. As will be shown 
below, these two acidic amino acids lead to significantly larger negative domains in the 
AA dimer at pH 4.8, which can interact with the large positive domain present at this pH 
for all possible dimers. The BB dimer's lack of A negative domain at this pH can 
suppress its self-aggregation. In the case of III where we start with AA and BB dimers as 
the initial reactants, BB is non-reactive and seems to suppress the aggregation of AA 
when it is present in suitable quantity. In the case II where AA, AB and BB dimers can 
exist, the observed aggregation could be due to that of AA and AB. The decrease in 
aggregation compared to that of (I) could be attributed to several reasons. The presence 
of BB dimer could be responsible for the suppression of the aggregation of AA and AB.  
Moreover, AB dimer lacks an aspartatecompared to AA, which might result in reduced 
aggregation. 
The initial rates of aggregation reported in figure 3 and 9 coupled with 
electrostatic modeling of the genetic variants seem to support the occurrence of some of 
the aggregation processes noted above. The AA dimer  (figure 12 F) with its large 
positive domain and small but significant negative domain is A unit which can interact 
with three other AA dimers BY accommodating two negative domains in its large 
positive domain, and one positive domain for its small negative domain (figure 13); Thus, 
AA behaves as an X(Y)2 unit (X and Y corresponding to negative and positive domains 
respectively). Figure 12 (F) also seems to explain the low rate of self-aggregation of BB 
dimers. This could be due to presence of only an incipient negative domain and a 
dominating positive domain at pH 4.8. The potential contours for BB at pH 4.8 show a 
negative domain so small as to be negligible so that this dimer behaves as a Y2 unit (with 
positive domains only). This not only makes it non-reactive with respect to self-
aggregation, but also leads to its ability to suppress the aggregation of AA. Figure 14 
depicts the suppression of aggregation of AA dimers by BB dimer, wherein the BB dimer 
with its significant positive potential suppresses the aggregation of AA dimers and at the 
same time prevents its own self propagation. 
 
 
(A) pH3.84 BLGAA 
 
 
pH3.84 BLGBB 
 
 
(B) pH4.03 BLGAA 
 
 
pH4.03 BLGBB 
 
 
(C) pH4.35 BLGAA 
 
 
pH4.35 BLGBB 
 
 
(D) pH4.45 BLGAA 
 
 
pH4.45 BLGBB 
 
  
(E)  pH4.59 BLGAA pH4.59 BLGBB 
 
) pH5.22 BLGAA  pH5.22 BLGBB 
Figure 12: 0.5 (blue) and -0.5(red) kT/e el contours around BLG A 
and B dimers at ionic strength 0.0045M. 
 
VI.B.1.6..  Two-Step Process 
Figure 13(A) shows the semi-logarithmic plot of BLG aggregation at pH 4.59 and 
I = 0.0045M supports the idea of a two step process.  A single, first-order process would 
xhibit a linear fit with a slope proportional to the rate constant. However, the obvious 
deviatio
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e
n at t = 5min indicates the presence of an initial mechanism with a higher rate 
constant. The initial rate is extremely sensitive to small changes in pH and depends 
strongly on the asymmetric electrostatic domains around the dimer; in particular the 
magnitude of the negative domain. The second process involves higher-order aggregati
of the particles formed in the initial step
on 
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use 
 by the 
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80. The second step does not seem to be sens
to the electrostatic domains around the dimer, but is related to the global charge, beca
it is inhibited by the accumulation of the global charge. In fact, the crossing of 
turbidimetric curves in Figure 13(B) and the crossing of turbidimetric curves (data not 
shown) from stopped flow spectrophotometer at different pH support the idea of primary 
and secondary steps having different pH dependencies. This is further supported
QELS results shown in Figure 7. QELS results show the presence of well defined 
aggregating species at sizes ranging from 6nm and 200 -  400nm. The 6nm particle size 
corresponds to the dimer which is the initial reactant and its reactivity determines the 
initial slope of the turbidity, which forms the step one of the two step process. The 
order particles ranging in the size of 100-200nm could be corresponding to the later 
process. 
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Figure 13(A): Exponential fitting for aggregation data of BLG 1g/L at pH 4.59, and at I= 
4.5 mM. Tα is the maximum transmittance value, k is a constant which is equal to ln(%T 
- %Tα) at time zero. Figure (B): Turbidity vs. time for BLG 1g/L, I = 4.5 mM at pH 
values from top to bottom: 4.82, 4.59, 5.22 and 3.84 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VI.C. INSULIN 
 
VI.C.1.RESULTS AND DISCUSSION 
 
VI.C.1.1.Effect of pH 
  
As seen in Figures 14 and 15, compared with Figures 1 and 3, the dependence of 
insulin aggregation on pH resembles the results obtained for BLG, but with some 
prominent distinguishing features. As is the case for BLG, the initial increase in turbidity 
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Figure 14. Turbidity vs. time for insulin 0.13g/L, I = 10mM (Sodium acetate) at pH 
values shown. 
 
shows a marked decrease when the initial pH deviates by +/- 0.1 pH unit from the pH of 
maximum aggregation, (pHmax) ca. 5.5. However, there are a number of significant 
differences. (1) While (dτ/dt)0 for BLG becomes zero at pH = pHmax + 0.7, zero 
aggregation is never seen for insulin in the pH range studied.  (2) Comparison of Figure 1 
and 14 shows the absence of a plateau in the case of insulin. (3) Comparison of Figure 2 
and 15 shows that the pH dependence is slightly symmetric for insulin with a maximum 
effect of pH below pHmax but, in case of BLG, more asymmetric with a maximum effect 
of pH on the higher side pHmax. (4) The maximum in (dτ/dt) 0 for insulin occurs at pH = 
pI, while it is seen at pH = pI - 0.5 for BLG. It is necessary to consider these marked 
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Figure 15. Initial Rate vs. pH for 0.13g/L insulin at 10mM ionic strength. 
 
differences in terms of the nonuniformity of the electrostatic domains for both proteins, 
and their implications for both multimer formation and aggregation. 
The effect of pH on the rate of aggregation of insulin can be distinguished from 
that of BLG in an alternative way. Figure 16 shows turbidimetric titrations of BLG and 
insulin, involving the addition of acid to a solution at pH 9.0 (“forward”), or the addition  
2 4 6 8
0
2
4
6
8
10
C
B
A
10
0 
- %
T
pH
 
Figure 16. Type 1 titrations of BLG “forward” (starting from pH 9.0) (A); and “reverse” 
(starting from pH 3.0) (B); and insulin “forward” (C), all at 0.5g/L I = 4.5mM and 10mM 
NaCl .  “Reverse” titration for insulin (not shown) is identical to “forward”. 
 
of base to a solution at pH 3.0 (“reverse”) (both of these referred to for historical reasons 
as “Type 1 titrations”). The base titration of insulin (not shown) coincides exactly  with 
its forward titration, i.e. full reversibility.  On the other hand the titrations of BLG reveal 
strong hysterisis, and incomplete reversibility. For example, BLG is strongly aggregated 
at pH 3.3 in the forward titration, but aggregation does not appear at this pH in the 
reverse titration, presumably showing the slowness of disaggregation in the forward 
titration. It might be surprising that maximum turbidity in the forward titration is seen at 
pH 4 – 3, which is well below pHmax.; this is because turbidity stops increasing (attains a 
maxium) when aggregation stops –[(dτ/dt)0 = 0 ] which according to Figure 2 is at pH 
3.8, and this is exactly where turbidity is a maximum in the “forward titration” of Figure 
16.  The decrease in turbidity at pH<4 in the forward titrtation corresponds to 
disaggregation, first slow, then rapid at pH<3.  In these titrations, attainment of a 
turbidity maximum indicates the end of the aggregation process and simultaneous 
initiation of the disruption of the aggregates due to increase in the repulsive forces. The 
point of maximum slope at pH ~ 4.5 in Figure 16A is the point of maximum (dτ/dt)0.  In 
fact, a tangent drawn to any point on the aggregating (right) side of the curve would give 
the rate of the aggregation and its pH-dependence would be Figure 2 , while a tangent 
drawn to any point on the other side of the curve would give the rate of disaggregation. 
Figure 17 portrays how these tangents change with pH. The process of forward 
aggregation stops at pH 4.0, however aggregation from low pH (Figure 16 B) starts at pH 
3.5. For a reversible reaction, both these pH values would have been the same.. Similarly, 
the derivative of the disaggregating phase of forward titration would give the (pH-
dependent) rate of disaggregation. Higher order aggregates formed in forward titration 
persist to pH 3.0, while a corresponding pH in Figure 2 shows aggregation rates close to 
zero.   
For insulin, forward and backward curves are identical, and both are nearly 
symmetrical, unlike BLG.  The reversibility of insulin aggregation could be due to 
aggregation in equilibrium with disaggregation36, i.e. reactants in equilibrium with the 
products. This pH dependent aggregation behavior as seen both in Figures 2 and 16A 
(BLG), and Figures 15 and 16B (insulin), arises from the distinctly different electrostatic 
properties and aggregation mechanisms of insulin and BLG.  
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Figure 17. Derivatives of Type 1 titrations of BLG : 1(a) forward aggregation, 1(b) 
forward disaggregation, 2 (a) reverse disaggregation 2(b) reverse aggregation. 
 
 
We consider the dimer to be the reactant for aggregation because (1) only dimer 
and hexamer have been reported in our pH range, and (2) the hexamer has a completely 
positive core85. The electrostatic models of the dimer in Figure 18 show approximately 
equal positive and negative lobes. These models do not show marked changes in the 
electrostatic potential contours in the regime of aggregation, and implicate linear 
aggregation, with the possibility of a negative domain of one dimer seating itself in the 
positive pocket of another, and so on. This can be visualized as a linear polymerizing 
chain of dimers in an (A-B) fashion, all of its subunits linked identically. The process of 
disaggregation would just involve removing a single oligomer from the aggregate. On the 
contrary, electrostatic models of BLG in the aggregating regime have a huge positive 
potential surface coupled with a small negative domain, which facilitates  A-(B)2 type of 
aggregation. The process of disaggregation for such a three dimensional aggregate would 
involve breaking many associations some of which are in the interior of an aggregate 
particle, consequently making the process of disaggregation  less reversible.  
The electrostatic domains influence multimer formation as well as aggregation. 
Electrostatic models of insulin reveal complementary positive and negative domains with 
a strongly preferred orientation for each connection zone, i.e. an orientational energy 
minimum. On the other hand, asymmetric potential domains seen in electrostatic models 
of BLG lead to complexes in which there are have multiple orientations of similar 
energy; this leads to formation of a loose non-specific aggregate. A single preferred 
binding orientation leads to formation of multimers, while formation of unstructured 
complexes occurs as a result of numerous binding configurations. Insulin forms well 
defined reversible, multimers involving monomer, dimer and, hexamer which are in 
equilibrium. For example, insulin hexamer has a well defined surface with its positive 
potential patches oriented to its core, and negative surface to the periphery. In contrast, 
BLG association is open ended, and involves formation of unstructured multimers.  
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Figure 18: 0.5(blue) and -0.5(red) kT/e electrostatic potential contours around insulin 
dimer at ionic strength 0.01M at pH 5.42, 5.52, 5.55, 5.61, 5.67, 5.82, 5.83, and 6.10. 
 
 The differences in the aforementioned pH dependent aggregation behavior for 
insulin vs.  BLG can be accounted for as follows. (1) In contrast to insulin, BLG 
aggregation usually attains a plateau with time. BLG aggregation is highest when the 
dimer has a net positive charge, and accumulated positive charge prevents indefinite 
aggregation. For insulin, on the other hand, pHmax = pI, where the net global charge 
would be close to zero, so aggregation occurs without charge accumulation. (2) pH 
dependence of aggregation in more asymmetric for BLG than for insulin. Asymmetry is 
seen in BLG when the rate depends very strongly on pH, especially at pH>pHmax. The 
asymmetry occurs as a result of large changes in the rate of aggregation with small 
changes in pH.because of the very strong influence of the small negative domain. In 
contrast, insulin requires symmetric positive and negative domains to aggregate. (3) The 
maximum rate of initial aggregation for  BLG, is at pHmax< pI where it has asymmetric 
electrostatic domains. For insulin pHmax= pI, where it has net charge of zero and 
symmetric electrostatic domains leading to a different aggregation behavior.  
 
VI.C.1.2.Effect of ionic strength 
 
The ionic strength dependence of aggregation of insulin studied by Type 1 
titrations shows maxium turbidity at 10 mM NaCl. (Figure 19). BLG was not examined 
in this way because of its irreversibility and complex time-dependence (Figure 5), but it 
would be expected to show a much lower aggregation at 50 mM and much larger 
aggregation at 1 mM. In contrast, maximum turbidity was observed in Figure 18 at 
10mM NaCl. At ionic strengths below and above 10mM NaCl, turbidity decreased 
suggesting a decrease in aggregation rate. The maxima in turbidity shifted to the lower 
pH’s with both increase and decrease in ionic strength. If the symmetry of these  type 1 
titration curves indicates reversibility, with aggregation increasing as pH is lowered 
towards pHmax, and disaggregation increasing as pH continues to fall below pHmax, 
then the maxima in turbidity represents a point where the net  aggregation is now zero, 
because the rates of aggregation  and disaggregation are equal. The point of maximum 
turbidity represents the initiation of disaggregation in a forward titration, and the 
initiation of aggregation in a reverse titration.  
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Figure 19. Ionic strength dependence of type I titration for insulin 0.1g/L at I = 0.5mM, 
5mM, 10mM, 30mM and, 50mM. 
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Figure 20. Ionic strength dependence of (dτ/dpH) at the pH of maximum aggregation rate 
(maximum negative slope in Figure  19) vs. I 
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Figure 21. 0.5(blue) and -0.5(red) kT/e electrostatic potential contours around insulin 
dimer at (A) pH 5.0, I = 0.5mM, (B) pH 5.2, I = 10mM and (C) pH 5.0, I = 50mM NaCl. 
 
Figure 20 shows dτ/dpH obtained from type 1 titrations of insulin (Figure 19). It 
is based on the assumption that dτ/dpH ≅ dτ/dt (this would be true if these increases in 
turbidity would occur even if the pH were held constant at the conditions of each data 
point. Support for this assumption comes from the fact that the pH at which dτ/dpH is 
maximum for BLG in the aggregation side of Figure 16A is nearly equal to pH 4.6 where 
dτ/dt)0 is maximum in Figure 3). Figure 20 is thought to resemble the result for  the true 
ionic strength dependence of the initial rate of aggregation for insulin. dτ/dpH for insulin 
shows a maximum at pH 5.5, I = 10mM. Maximum aggregation of insulin in 10mM 
sodium chloride can be considered in terms of the Debye-Huckel screening length κ-1. 
The distance between the centers of mass of two adjacent dimers a and b is 3 nm, so a 
screening length of 3 nm allows interaction between the positive domain of a (a+) and 
the negative domain of b (b-). This corresponds to I = 10 mM.  At low salt, e.g. 0.5 mM, 
κ-1 = about 13 nm, so that repulsions, a+ interacting with b+ and a- with b- also occur. At 
high salt, e.g. 50 mM NaCl, κ-1 = 1.3 nm, which diminishes the attractive interaction 
between a+ and b-. These points are shown in Figure 21, where there is a marked positive 
potential domain for 5 mM, and completely screened potentials at 50mM But at 10mM, 
the intermolecular distance in the aggregating species would be equal to the screening 
length. Allowing the positive potential surface of a dimer to only see the negative surface 
of another dimer. This interaction could lead to the propagation of a linear chain. 
 
 
 
 
 
 
 
VII. CONCLUSION 
 
The pH dependence of BLG aggregation is markedly asymmetric. Maximum 
aggregation rates were observed in the pH range 4.3 to 4.8, below isoelectric point of 5.2, 
so that where positive potential domains are larger than negative ones. This is explained 
by the hypothesis that such asymmetry makes it possible for each aggregating subunit 
(BLG dimer) to interact with three other such dimers, the optimal condition for such 
interaction providing a relatively small but not negligible negative domain. The rate of 
aggregation strongly increased with decrease in ionic strength I and was found to be 
nearly linear with 1/I; suppression of aggregation at high ionic strengths is due to the 
screening of attractive forces. The aggregation mechanism of BLG can be explained by a 
two-step process in which the initial reactant (dimer), rapidly forms intermediate clusters 
(200 nm) and these clusters further associate, rather slowly, to form much larger 
aggregates (800 nm). The growth of the larger clusters may be limited by the 
accumulation of excess charge. 
The aggregation of insulin is different in many was from that of BLG. (1) Insulin 
aggregation was maximum at its pI (5.5) where positive and negative domains are of 
equal magnitude. (2) The ionic strength dependence of insulin aggregation doesn’t seem 
to have a linear relationship with 1/I, but instead decreases with both increase and 
decrease in ionic strength. The highest rate of aggregation at I = 10mM can be explained 
by the ideal Debye-Huckel screening length of the insulin dimer. (3) Type I titrations of 
insulin are completely reversible, unlike that of BLG which took a hysterisis. This 
reversibility of insulin can be explained by the symmetric domains of the dimer which 
have strong preferential orientation. In case of the BLG which has multiple orientations 
of similar energy aiding in the formation of loose specific aggregates results in 
irreversibility. (4) Electrostatic modeling has been used to understand pH and ionic 
strength dependence of insulin and BLG aggregation and the resulting inter-
macromolecular effects related to protein charge heterogeneity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VIII. FUTURE WORK 
 
• Size exclusion chromatography of BLG and insulin needs to be carried out to 
determine the size of the predominant aggregating species. 
 
• Aggregation experiments should be carried out with insulin to determine the ionic 
strength dependence of initial rate of aggregation. 
 
• Light scattering studies of insulin should be done to determine the species 
involved in insulin aggregation. 
 
• Aggregation studies can be extended to other globular proteins like serum 
albumin and lysozyme to determine whether electrostatics can be implicated in 
their aggregation behavior as well. 
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